Maarten Kraan Founder of Citryll Backed byNovartis Venture FundArgeris Karabelas LinkedIn SourcesCitryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders — 2024-12 Browse all founders · Browse investors
